• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Gallbladder Cancer

Gallbladder Cancer - 22 Studies Found

Completed : Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer
:
  • Extrahepatic Bile Duct Cancer
  • Gallbladder Cancer
  • : 2001-02-02
    :
    • Drug: fluorouracil
    • Drug: gemcitabine hydro

Completed : Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer
: Gallbladder Cancer
: 1999-11-01
: Drug: irinotecan hydrochloride
Terminated : Study to Test the Benefit and Safety of GM-CT-01 in Combination With 5-FU to Treat Bile Duct and Gall Bladder Cancer
:
  • Cancer of the Bile Duct
  • Gallbladder Cancer

: 2006-10-10
:
  • Drug: GM-CT-01 GM-CT-01 at 280

Completed : Gemcitabine and Cisplatin for Gallbladder and Biliary Tract Cancer
:
  • Gallbladder Cancer
  • Biliary Tract Cancer

: 2005-07-25
:
  • Drug: Gemcitabine
  • Drug: Cisplatin

Completed : Dolastatin 10 in Treating Patients With Metastatic Or Recurrent Liver, Bile Duct, or Gallbladder Cancer
:
  • Extrahepatic Bile Duct Cancer
  • Gallbladder Cancer
  • : 1999-11-01
    : Drug: dolastatin 10
Completed : DX-8951f in Treating Patients With Biliary Cancer
:
  • Extrahepatic Bile Duct Cancer
  • Gallbladder Cancer
  • : 2000-07-05
    : Drug: exatecan mesylate
Completed : S0514 Sorafenib in Treating Patients With Unresectable or Metastatic Gallbladder Cancer or Cholangiocarcinoma
:
  • Adenocarcinoma of the Extrahepatic Bile Duct
  • Adenocarcinoma of the Gallbladder
  • : 2005-10-12
    :
    • Drug: sorafenib tosylate Given

Completed : Trastuzumab in Treating Patients With Locally Advanced or Metastatic Gallbladder Cancer or Bile Duct Cancer That Cannot Be Removed by Surgery
:
  • Adenocarcinoma of the Extrahepatic Bile Duct
  • Adenocarcinoma of the Gallbladder
  • : 2007-05-23
    :
    • Biological: trastuzumab For HE

Completed : Initial Study of Gallbladder Cancer in Chile
: Gallbaldder Cancer
: 2012-01-26
Completed : Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma
:
  • Extrahepatic Bile Duct Adenocarcinoma
  • Gallbladder Adenocarcinoma
  • Drug: Erlotinib Hydrochloride

<<< Previous | Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.